NuCana PLC (NCNA)
3.67
-0.11
(-2.91%)
USD |
NASDAQ |
May 16, 16:00
3.67
0.00 (0.00%)
Pre-Market: 20:00
NuCana Price to Book Value: 0.4092 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 16, 2024 | 0.4092 |
May 15, 2024 | 0.4214 |
May 14, 2024 | 0.4326 |
May 13, 2024 | 0.4159 |
May 10, 2024 | 0.4003 |
May 09, 2024 | 0.3902 |
May 08, 2024 | 0.4092 |
May 07, 2024 | 0.4359 |
May 06, 2024 | 0.4326 |
May 03, 2024 | 0.446 |
May 02, 2024 | 0.4421 |
May 01, 2024 | 0.4437 |
April 30, 2024 | 0.4415 |
April 29, 2024 | 0.446 |
April 26, 2024 | 0.446 |
April 25, 2024 | 0.4248 |
April 24, 2024 | 0.4281 |
April 23, 2024 | 0.446 |
April 22, 2024 | 0.4449 |
April 19, 2024 | 0.4209 |
April 18, 2024 | 0.4226 |
April 17, 2024 | 0.4426 |
April 16, 2024 | 0.4348 |
April 15, 2024 | 0.4961 |
April 12, 2024 | 0.6241 |
Date | Value |
---|---|
April 11, 2024 | 0.6595 |
April 10, 2024 | 0.6595 |
April 09, 2024 | 0.6617 |
April 08, 2024 | 0.6578 |
April 05, 2024 | 0.6486 |
April 04, 2024 | 0.667 |
April 03, 2024 | 0.7311 |
April 02, 2024 | 0.6405 |
April 01, 2024 | 0.6606 |
March 28, 2024 | 0.7247 |
March 27, 2024 | 0.8547 |
March 26, 2024 | 0.8529 |
March 25, 2024 | 0.8747 |
March 22, 2024 | 0.8476 |
March 21, 2024 | 0.8075 |
March 20, 2024 | 0.9273 |
March 19, 2024 | 0.9321 |
March 18, 2024 | 1.023 |
March 15, 2024 | 0.9719 |
March 14, 2024 | 1.089 |
March 13, 2024 | 1.171 |
March 12, 2024 | 1.072 |
March 11, 2024 | 0.9198 |
March 08, 2024 | 0.9237 |
March 07, 2024 | 0.9198 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3902
Minimum
May 09 2024
4.896
Maximum
May 24 2019
1.600
Average
1.331
Median
Oct 13 2023
Price to Book Value Benchmarks
Adaptimmune Therapeutics PLC | 7.496 |
Biodexa Pharmaceuticals Plc | 0.9124 |
Autolus Therapeutics PLC | 9.709 |
Mereo BioPharma Group PLC | 9.076 |
Bicycle Therapeutics PLC | 2.372 |
Price to Book Value Related Metrics
Price | 3.67 |
Earnings Yield | -448.5% |
Market Cap | 7.760M |